by BioKier | Oct 1, 2019 | Recent News
BioKier completed a four-week clinical study with BKR-013 (L-glutamine in colon-targeted, sustained-release capsules) in Type 2 diabetes patients, who were already being treated with approved anti-diabetes drugs. This study was supported by an NIH SBIR grant. Fourteen...
by BioKier | Jan 1, 2018 | Recent News
BioKier initiated a clinical trial of BKR-013 colon-targeted capsules in collaboration with Pennington Biomedical Research Center, Baton Rouge, LA. This study will examine the Effect of BKR-013 on Average Daily Glucose Levels. This trial is registered on...
by bigpixel | Feb 7, 2017 | Recent News
BioKier has published an article summarizing our pre-clinical and clinical research: “Colonic delivery of nutrients for management of blood glucose in type 2 diabetes patients”. The data validate BioKier’s approach to managing glucose using colon-targeted nutrients....
by BioKier | Jan 14, 2017 | Recent News
Dr. George Szewczyk, presented at the 5th Annual World Congress of Food and Nutrition, held November 18-20, 2016, at The Conference Venue – Kaohsiung Exhibition Center in Kaohsiung, Taiwan. This presentation,” Role of nutrients in metabolic diseases resolution...
by BioKier | Oct 19, 2016 | Recent News
Dr. Jennifer Law of Encap Drug Delivery, A Division of Capsugel, Livingston, West Lothian, Scotland, United Kingdom, presented at the conference “The Science of Medicine“ held 5th – 7th September 2016 at Technology and Innovation Centre, University of...
by BioKier | Oct 13, 2016 | Recent News
Dr. George Szewczyk, on behalf of BioKier, Inc., presented at the 20th International Conference of Functional and Medical Foods for Chronic Diseases held September 22-23, 2016, at The Joseph B. Martin Conference Center at Harvard Medical School, Boston, USA. This...
